It is time to change US trade policy to foster access to medicines

2020 ◽  
Vol 9 (1) ◽  
pp. 25-27
Author(s):  
Maria Fabiana Jorge

While Americans are deeply concerned about drug prices, the United States Trade Representative (USTR) continues to negotiate agreements like the United States-Mexico-Canada Agreement (USMCA) that put at risk the sustainability of the generics industry and undermine the development of biosimilars that play a critical role in access to medicines. It is time to restore some balance to US trade policy.

Subject US trade policy after the China and USMCA deals. Significance US President Donald Trump approved the United States-Mexico-Canada Agreement (USMCA) on January 29 after Mexico approved it in December. Canada will almost certainly approve it, having begun the ratification process on January 27. The USMCA signing, coming soon after Chinese and US officials signed phase one of their trade agreement on January 16, is the most significant activity on international trade thus far by the US administration. Impacts US trade policy will continue to focus on bilateral deals. Trump benefits politically from attacking US trade imbalances, which his supporters view as having only hurt US industry and commodities. Trump may see the USMCA and China deals as fleeting successes; he might redouble his efforts and pursue stricter deals if re-elected.


2021 ◽  
Vol 17 (1) ◽  
Author(s):  
Anna S. Y. Wong ◽  
Clarke B. Cole ◽  
Jillian C. Kohler

Abstract Background Transparency and accountability are essential components at all stages of the trade negotiation process. This study evaluates the extent to which these principles were upheld in the United States’ public consultation process during the negotiation of the United States-Mexico-Canada Agreement (USMCA), with respect to public comments about the pharmaceutical sector and access to medicines. Results The public consultation process occurred before the start of official negotiations and was overseen by the Office of the United States Trade Representative (USTR). It included both written comments and oral testimony about US trade negotiation objectives. Of the written comments that specifically discussed issues relating to pharmaceuticals, the majority were submitted by private individuals, members of the pharmaceutical industry, and civil society organizations. Nearly all comments submitted by non-industry groups indicated that access to medicines was a priority issue in the renegotiated agreement, with specific reference to price affordability. By contrast, more than 50% of submissions received from members or affiliates of the pharmaceutical industry advocated for strengthened pharmaceutical intellectual property rights, greater regulatory data protections, or both. This study reveals mixed outcomes with respect to the level of transparency achieved in the US trade negotiation process. Though input from the public at-large was actively solicited, the extent to which these comments were considered in the content of the final agreement is unclear. A preliminary comparison of the analyzed comments with the USTR’s final negotiating objectives and the final text of the USMCA shows that several provisions that were advanced exclusively by the pharmaceutical industry and ultimately adopted in the final agreement were opposed by the majority of non-industry stakeholders. Conclusions Negotiators could increase public transparency when choosing to advance one competing trade objective over another by actively providing the public with clear rationales for their negotiation positions, as well as details on how public comments are taken into account to form these rationales. Without greater clarity on these aspects, the public consultation process risks appearing to serve as a cursory government mechanism, lacking in accountability and undermining public trust in both the trade negotiation process and its outcomes.


Subject US trade policy. Significance US President Donald Trump announced on March 22 that within 15 days a list of more than 1,000 Chinese imports to be subject to 25% tariffs will be released for 30 days of public comment. This could herald wider protectionist policies: the rhetoric of Trump's team may suggest its goal is to establish 'fair' trade, letting markets determine pricing and observing copyrights and patents, but the move also represents a key step in the fundamental 15-year US policy shift towards autarky. Impacts Forecasters were slow to see that US shale advances 15 years ago would alter energy markets -- now manufacturing too could change markedly. The United States may extend its shale experience to other sectors to reduce its imports substantially. If the United States becomes less dependent on certain regions for key imports, the government will gain foreign policy flexibility.


2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Jiandong Shi

This paper analyzes the direct cause of China–United States trade war, a trade imbalance between China and the United States, and summarizes the causes of this trade imbalance. I have discussed the trade imbalance from the three perspectives of trade structure, trade mode, and trade policy, which focus on the respective trade policies of China and the United States. Moreover, I have examined the subjective factors affecting the trade imbalance between China and the United States. A significant impact of trade policies on trade imbalance has been demonstrated in this study to call for attention from both sides.


Author(s):  
V. Iordanova ◽  
A. Ananev

The authors of this scientific article conducted a comparative analysis of the trade policy of US presidents Barack Obama and Donald Trump. The article states that the tightening of trade policy by the current President is counterproductive and has a serious impact not only on the economic development of the United States, but also on the entire world economy as a whole.


Author(s):  
Jean H. Baker

Building America: The Life of Benjamin Henry Latrobe is a biography of America’s first professionally trained architect and engineer. Born in 1764, Latrobe was raised in Moravian communities in England and Germany. His parents expected him to follow his father and brother into the ministry, but he rebelled against the church. Moved to London, he studied architecture and engineering. In 1795 he emigrated to the United States and became part of the period’s Transatlantic Exchange. Latrobe soon was famous for his neoclassical architecture, designing important buildings, including the US Capitol and Baltimore Basilica as well as private homes. Carpenters and millwrights who built structures more cheaply and less permanently than Latrobe challenged his efforts to establish architecture as a profession. Rarely during his twenty-five years in the United States was he financially secure, and when he was, he speculated on risky ventures that lost money. He declared bankruptcy in 1817 and moved to New Orleans, the sixth American city that he lived in, hoping to recoup his finances by installing a municipal water system. He died there of yellow fever in 1820. The themes that emerge in this biography are the critical role Latrobe played in the culture of the early republic through his buildings and his genius in neoclassical design. Like the nation’s political founders, Latrobe was committed to creating an exceptional nation, expressed in his case by buildings and internal improvements. Additionally, given the extensive primary sources available for this biography, an examination of his life reveals early American attitudes toward class, family, and religion.


Sign in / Sign up

Export Citation Format

Share Document